Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Tandlægeselskabet Storgade 29A, Sorø ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.5% 0.5%   Bankruptcy risk   10.8% 9.2% 5.2% 6.0% 6.5% 6.2% 15.9% 15.9%   Credit score (0-100)   24 28 42 37 36 37 12 12   Credit rating   BB BB BBB BBB BBB BBB BB BB   Credit limit (kDKK)   -0.0 -0.0 -0.0 0.0 0.0 0.0 -0.0 -0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   1,420 2,457 1,665 2,605 2,076 2,845 0.0 0.0   EBITDA   -703 -52.5 410 814 119 255 0.0 0.0   EBIT   -959 -262 207 562 54.5 167 0.0 0.0   Pre-tax profit (PTP)   -1,042.1 -305.7 167.9 547.5 48.7 144.4 0.0 0.0   Net earnings   -970.5 156.5 130.9 426.5 36.0 112.2 0.0 0.0   Pre-tax profit without non-rec. items   -1,042 -306 168 547 48.7 144 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   588 379 235 244 180 300 0.0 0.0   Shareholders equity total   -1,014 -857 -726 -300 -264 -152 -407 -407   Interest-bearing liabilities   1,401 1,443 1,194 1,274 1,412 1,605 407 407   Balance sheet total (assets)   889 1,179 1,041 1,289 1,497 1,812 0.0 0.0   Net Debt   1,399 1,436 999 1,221 1,385 1,588 407 407     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   1,420 2,457 1,665 2,605 2,076 2,845 0.0 0.0   Gross profit growth   38.2% 73.1% -32.2% 56.4% -20.3% 37.0% -100.0% 0.0%   Employees   6 7 4 5 5 6 0 0   Employee growth %   -33.3% 16.7% -42.9% 25.0% 0.0% 20.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   889 1,179 1,041 1,289 1,497 1,812 0 0   Balance sheet change%   -33.7% 32.6% -11.7% 23.8% 16.1% 21.0% -100.0% 0.0%   Added value   -703.2 -52.5 409.8 813.9 306.0 255.0 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -512 -418 -346 -243 -274 31 -300 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   -3.0 -4.0 1.0 2.0 3.0 4.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   -67.6% -10.6% 12.4% 21.6% 2.6% 5.9% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   -44.5% -13.3% 10.9% 33.5% 4.3% 10.5% 0.0% 0.0%   ROI %   -58.0% -17.8% 14.7% 44.0% 5.4% 12.8% 0.0% 0.0%   ROE %   -87.1% 15.1% 11.8% 36.6% 2.6% 6.8% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   -53.3% -42.1% -41.1% -18.9% -15.8% -7.9% -100.0% -100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -198.9% -2,734.7% 243.8% 150.0% 1,168.2% 622.8% 0.0% 0.0%   Gearing %   -138.2% -168.3% -164.4% -425.0% -534.9% -1,057.4% -100.0% -100.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   5.4% 3.1% 3.0% 1.2% 1.7% 3.4% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.1 0.4 0.5 0.6 0.8 0.8 0.0 0.0   Current Ratio   0.2 0.4 0.5 0.7 0.7 0.8 0.0 0.0   Cash and cash equivalent   2.5 6.8 194.9 53.6 27.2 16.7 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -1,601.5 -1,138.4 -875.6 -544.0 -444.0 -425.4 -203.4 -203.4   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   -117 -8 102 163 61 42 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   -117 -8 102 163 24 42 0 0   EBIT / employee   -160 -37 52 112 11 28 0 0   Net earnings / employee   -162 22 33 85 7 19 0 0